Print PRINT
X
DisCoVisc® OVDs

The First Viscous Dispersive

DisCoVisc® OVD is a single OVD designed for the entire cataract procedure. The first viscous dispersive, DisCoVisc® OVD provides superior endothelial protection, space maintenance, ease of movement, and ease of removal.

DisCoVisc® OVD

Go Further with One Syringe Than Ever Before

With DisCoVisc® OVD, one syringe is all you need—from the first incision through implantation. The key is Chondroitin Sulfate.

The One OVD Designed for the Entire Surgery

How far can one OVD take you? In a series of randomized, controlled trials, DisCoVisc® OVD rated highest for both performance and overall satisfaction. The findings, listed below, are available in the product insert.

FDA Study: DisCoVisc® OVD vs. Healon* OVD

The FDA compared DisCoVisc® OVD with Healon* OVD in a randomized, observer-masked, multi-center clinical trial.1 The trial tested each of the OVDs’ properties during cataract extraction and IOL implantation.

249 patients (128 DisCoVisc® OVD and 121 Healon* OVD) were evaluated for safety and efficacy.

Dispersive and Cohesive Properties See More

In surgery, your OVD must have the right properties at the right time. DisCoVisc® OVD was tested at 3 phases of cataract surgery.

Capsulorhexis
During Capsulorhexis, DisCoVisc® OVD was described as having dispersive properties in over 78% of cases.

Viscoelastic Properties During Capsulorhexis

DisCoVisc® Performance: Viscoelastic Properties During Capsulorhexis

Phacoemulsification
During phacoemulsification, DisCoVisc® OVD was described as having dispersive properties in over 88% of cases.

Viscoelastic Properties During Phacoemulsification

DisCoVisc® Performance: Viscoelastic Properties During Phacoemulsification

Removal
In contrast, during removal, DisCoVisc® OVD was described as having cohesive properties in over 87% of cases.

Viscoelastic Properties During Removal

DisCoVisc® Performance: Viscoelastic Properties During Removal

Space MaintenanceSee More

How well does DisCoVisc® OVD maintain space in the anterior chamber? DisCoVisc® OVD was tested at 3 phases of cataract surgery.

Capsulorhexis
Space maintenance was statistically superior during Capsulorhexis.

Anterior Chamber and Dome Maintenance During Anterior Capsulotomy

DisCoVisc® Performance: Anterior Chamber Depth/Dome Maintenance During Anterior Capsulotomy

Phacoemulsification
Space maintenance was statistically superior during phacoemulsification.

Anterior Chamber Depth/Dome Maintenance During Phacoemulsification

DisCoVisc® Performance: Anterior Chamber Depth/Dome Maintenance During Phacoemulsification

Removal
Space maintenance was statistically superior during removal.

Protection, Visualization and Overall See More

See how fellow physicians rated each OVD on visualization and overall satisfaction.

Visualization
DisCoVisc® OVD was statistically superior to Healon* for visualization during the procedure.

Visualization

DisCoVisc® Performance: Visualization

Overall Satisfaction
Regardless of preference for cohesive or dispersive, surgeons were satisfied with the performance of DisCoVisc® OVD in over 96% of cases.

Satisfaction with Viscoelastic Performance

DisCoVisc® Performance: Satisfaction and Viscoelastic Performance

For optimized solutions in a single syringe, choose the OVD designed for the entire procedure.

Ready to learn more about DisCoVisc® OVD? Visit our Product Details page for a complete product profile, specifications, and more.

View Important Product Information for
DisCoVisc® OVD+

DisCoVisc® OVD

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.

Description: DisCoVisc® Ophthalmic Viscosurgical Device has an intermediate cohesive/dispersive index (CDI) and can best be described as the first viscous dispersive viscoelastic and is optimized for the entire surgical procedure.

Indications: DisCoVisc® Ophthalmic Viscosurgical Device is indicated for use during surgery in the anterior segment of the eye. It is designed to create and maintain space, to protect the corneal endothelium and other intraocular tissues and to manipulate tissues during surgery. It may also be used to coat intraocular lenses and instruments during cataract extraction and IOL insertion.

Warnings: Failure to follow assembly instructions or use of an alternate cannula may result in cannula detachment and potential patient injury.

Precautions: Precautions are limited to those normally associated with the surgical procedure being performed. Although sodium hyaluronate and sodium chondroitin sulfate are highly purified biological polymers, the physician should be aware of the potential allergic risks inherent in the use of any biological material.

Adverse Reactions: DisCoVisc® Ophthalmic Viscosurgical Device was very well tolerated in nonclinical and clinical studies. A transient rise in intraocular pressure in the early postoperative period may be expected due to the presence of sodium hyaluronate, which has been shown to effect such a rise. It is therefore recommended that DisCoVisc® OVD be removed from the anterior chamber by thorough irrigation and/or aspiration at the end of surgery to minimize postoperative IOP increases. Do not overfill anterior chamber.

Attention: Reference the Physician Labeling/Directions for Use for a complete listing of indications, warnings and precautions.

DUOVISC® OVD +

DUOVISC® OVD

Description: DUOVISC® Viscoelastic System is designed to give two Viscoelastic materials with different physico-chemical properties that can be used differently and/or sequentially to perform specific tasks during a cataract procedure. DUOVISC® Viscoelastic System consists of VISCOAT® Ophthalmic Viscosurgical Device and PROVISC® Ophthalmic Viscosurgical Device.

Caution: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

Description: VISCOAT® (Sodium Chondroitin Sulfate – Sodium Hyaluronate) Ophthalmic Viscosurgical Device

Indications: VISCOAT® OVD is indicated for use as an ophthalmic surgical aid in anterior segment procedures including cataract extraction and intraocular lens (IOL) implantation. VISCOAT® OVD maintains a deep anterior chamber during anterior segment surgeries, enhances visualization during the surgical procedure, and protects the corneal endothelium and other ocular tissues. The viscoelasticity of the solution maintains the normal position of the vitreous face and prevents formation of a flat chamber during surgery.

Warnings: Failure to follow assembly instructions or use of an alternate cannula may result in cannula detachment and potential patient injury.

Precautions: Precautions are limited to those normally associated with the surgical procedure being performed. Although sodium hyaluronate and sodium chondroitin sulfate are highly purified biological polymers, the physician should be aware of the potential allergic risks inherent in the use of any biological material.

Adverse Reactions: VISCOAT® OVD has been extremely well tolerated in human and animal studies. A transient rise in intraocular pressure in the early postoperative period may be expected due to the presence of sodium hyaluronate, which has been shown to effect such a rise. It is therefore recommended that VISCOAT® OVD be removed from the anterior chamber by thorough irrigation and/or aspiration at the end of surgery to minimize postoperative IOP increases. Do not overfill anterior chamber.

ATTENTION: Reference the Physician Labeling/Directions for Use for a complete listing of indications, warnings and precautions.

Description: PROVISC® (Sodium Hyaluronate) Ophthalmic Viscosurgical Device

Indications: PROVISC® OVD is indicated for use as an ophthalmic surgical aid in the anterior segment during cataract extraction and intraocular lens (IOL) implantation. Ophthalmic viscoelastics serve to maintain a deep anterior chamber during anterior segment surgery allowing reduced trauma to the corneal endothelium and surrounding ocular tissues. They help push back the vitreous face and prevent formation of a flat chamber during surgery.

Precautions: Postoperative increases in intraocular pressure have been reported with sodium hyaluronate products. The IOP should be carefully monitored and appropriate therapy instituted if significant increases should occur. It is recommended that PROVISC® OVD be removed by irrigation and/or aspiration at the close of surgery. Do not overfill anterior chamber. Although sodium hyaluronate is a highly purified biological polymer, the physician should be aware of the potential allergic risks inherent in the use of any biological material; care should be used in patients with hypersensitivity to any components in this material. Cannula assembly instructions should be followed to prevent patient injury.

Adverse Reactions: Postoperative inflammatory reactions such as hypotony and iritis have been reported with the use of ophthalmic viscoelastics, as well as incidents of corneal edema, corneal decompensation, and a transient rise in intraocular pressure. It is therefore recommended that PROVISC® OVD be removed from the anterior chamber by thorough irrigation and/or aspiration at the end of surgery to minimize postoperative IOP increases. Do not overfill anterior chamber.

Attention: Reference the Physician Labeling/Directions for Use for a complete listing of indications, warnings and precautions.

[an error occurred while processing this directive]

GRIESHABER® Aspheric Lens

Indications for Use: The GRIESHABER® DSP Aspheric Macular Lens is used to visualize the fundus and retinal structures during vitreoretinal surgery. It is designed as a self-retaining contact lens to allow hands-free operation.

Caution: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

Warnings and Precautions:

  • The device may be used only by well trained physicians and personnel.
  • Potential risk from reuse or reprocessing include: reduced optical quality, surface damage on the optics, and foreign particle introduction to the eye.
  • The surgeon’s team has to ensure that sufficient viscous fluid is available throughout usage of the lens for continuous humidification of the cornea.

Attention: Reference the Directions for Use for a complete listing of indications, warnings, and precautions.